Atracurium Besylate Injection USP 10mg/ml – Leading Manufacturer & Supplier PAN India
Taj Pharma India, based in Vapi, Gujarat, stands as a pioneer in the pharmaceutical manufacturing landscape, delivering world-class solutions to global markets. Among our wide portfolio of critical care drugs, we specialize in the manufacturing, supply, and export of Atracurium Besylate Injection USP 10mg/ml, a vital neuromuscular blocking agent used across operating rooms and ICUs. With a strong presence in Mumbai, Maharashtra, and distribution capabilities PAN India, Taj Pharma is the preferred partner for healthcare providers, hospitals, and PCD pharma franchise holders.
What is Atracurium Besylate Injection USP 10mg/ml?
Atracurium Besylate Injection USP 10mg/ml is a non-depolarizing skeletal muscle relaxant primarily used in anesthesia. It facilitates muscle relaxation during surgery and assists with endotracheal intubation and mechanical ventilation. This intravenous medication ensures controlled neuromuscular blockade, making it indispensable in operating rooms and intensive care settings.
Therapeutic Applications of Atracurium Besylate Injection
- Adjunct to General Anesthesia – Enhances surgical conditions by inducing muscle paralysis.
- Facilitates Intubation – Eases insertion of an endotracheal tube by relaxing vocal cords and tracheal muscles.
- Supports Mechanical Ventilation – Ensures immobility and synchrony with ventilators in ICU patients.
- Emergency Airway Management – Effective during rapid sequence induction for critical care situations.
Why Choose Taj Pharma as Your Atracurium Besylate Injection Manufacturer?
1. WHO-GMP Certified Manufacturing Facilities
Our production units are equipped with advanced sterile processing technology, ensuring contamination-free injectable manufacturing. Each batch of Atracurium Besylate undergoes rigorous in-process and finished product quality checks.
2. PAN India and Global Supply Chain
From Mumbai to Delhi, Chennai to Kolkata, our logistics infrastructure enables timely delivery across India. Internationally, we serve clients in Africa, the Middle East, LATAM, and Southeast Asia, backed by reliable freight and regulatory clearance services.
3. Regulatory Excellence
We provide full regulatory support including CTD/ACTD dossiers, bioequivalence data, stability studies, and COAs, allowing seamless registrations in multiple markets.
4. Cost-Effective Pricing
With large-scale production capabilities, we offer competitive pricing without compromising on quality. We also accommodate bulk procurement and institutional supply contracts.
5. Customizable Solutions
We offer private labeling, custom packaging, and branding support to our global partners, enhancing product visibility and market appeal.
Composition and Packaging
- Active Ingredient: Atracurium Besylate
- Strength: 10mg/ml
- Dosage Form: Injectable solution
- Packaging: 10ml glass vial, available in packs of 1 vial per box
- Storage: Store in refrigeration between 2°C to 8°C. Protect from light.
Dosage & Administration
Atracurium Besylate should be administered intravenously only under the supervision of trained medical professionals. The dose varies depending on the patient’s body weight, anesthetic technique, and expected duration of surgical procedure.
Initial Dose (Adults):
- 0.4 to 0.5 mg/kg as a bolus over 60 seconds.
Maintenance Dose:
- 0.08 to 0.10 mg/kg at 20 to 45-minute intervals, as required.
Infusion:
- Continuous infusion may be initiated to maintain desired muscle relaxation.
Note: No dose adjustment is typically needed in renal impairment; however, caution is advised in patients with liver dysfunction or acid-base imbalance.
Safety and Precautions
- Pregnancy: Use only if clearly needed. Animal studies show potential fetal risk.
- Breastfeeding: Likely safe as the drug has a short half-life and minimal systemic exposure.
- Kidney Disease: Safe; Atracurium is degraded by Hofmann elimination, independent of renal function.
- Hepatic Impairment: Dose modification may be necessary.
Adverse Effects
Although generally well-tolerated, some patients may experience:
- Skin flushing
- Transient hypotension
- Bronchospasm (rare)
- Injection site pain or redness
Report all side effects to your healthcare provider immediately.
PCD Pharma Franchise – Atracurium Besylate Injection USP 10mg/ml
Taj Pharma offers exclusive PCD pharma franchise opportunities for Atracurium Besylate Injection across India. Our franchise partners benefit from:
- Monopoly rights in select territories
- Promotional materials & marketing support
- Timely product supply
- Affordable pricing & high margins
We are actively seeking franchise partners in Maharashtra, Gujarat, Punjab, Rajasthan, Tamil Nadu, Karnataka, and Kerala.
Atracurium Besylate Injection Manufacturer from Mumbai & Vapi
Our injectable units located in Mumbai and Vapi enable us to serve both domestic and international markets efficiently. Our capabilities include:
- Large-scale production
- Contract manufacturing services
- Exports to regulated and semi-regulated markets
We adhere strictly to pharmacopoeial standards (USP/BP/Ph.Eur) and ensure product consistency across all batches.
Global Exporter of Atracurium Besylate Injection USP 10mg/ml
Taj Pharma proudly exports Atracurium Besylate to:
- Africa (Nigeria, Kenya, South Africa, Ghana)
- Middle East (UAE, Saudi Arabia, Oman)
- Latin America (Peru, Chile, Colombia)
- Asia-Pacific (Vietnam, Philippines, Myanmar)
We are recognized for timely delivery, robust documentation, and long-term partnerships in over 42 countries.
Atracurium Besylate Injection USP 10mg/ml at Best Price in India
We offer affordable pricing for Atracurium Besylate Injection across Mumbai, Maharashtra, and all major Indian cities. Hospitals, government institutions, pharma distributors, and healthcare professionals trust Taj Pharma for:
- Unmatched product quality
- Prompt delivery
- Comprehensive support
Connect with Taj Pharma India
Partner with one of the most reliable pharmaceutical companies in India. For Atracurium Besylate Injection USP 10mg/ml manufacturing, PCD franchise, or export inquiries, reach out today.
📧 Email: info@tajpharma.com
📱 Phone: +91 84484 44095
📲 WhatsApp: +91 7400009975 / 7400009976
🌐 Website: www.tajpharmaindia.com
